O'Shaughnessy Asset Management, LLC Opiant Pharmaceuticals, Inc. Transaction History

O'Shaughnessy Asset Management, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 11, 2022	SELL	$22.51 - $36.79 $922 - $1,508	-41 Closed	0 $0
Q3 2021 Nov 10, 2021	BUY	$13.28 - $25.79 $544 - $1,057	41 New	41 $1,000
Q4 2018 Feb 12, 2019	SELL	$13.84 - $18.79 $46,267 - $62,814	-3,343 Closed	0 $0
Q3 2018 Nov 06, 2018	SELL	$12.89 - $23.43 $13,998 - $25,444	-1,086 Reduced 24.52%	3,343 $60,000
Q2 2018 Aug 10, 2018	SELL	$14.31 - $20.59 $14,066 - $20,239	-983 Reduced 18.16%	4,429 $63,000
Q1 2018 May 08, 2018	SELL	$18.8 - $26.5 $34,216 - $48,230	-1,820 Reduced 25.17%	5,412 $104,000
Q4 2017 Feb 13, 2018	BUY	$18.16 - $40.15 $93,215 - $206,089	5,133 Added 244.55%	7,232 $166,000
Q3 2017 Nov 13, 2017	BUY	$15.23 - $50.5 $31,967 - $105,999	2,099	2,099 $77,000

300

Ticker OPNT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 5,164,150
Description
Opiant Pharmaceuticals, Inc., a specialty pharmaceutical company, develops medicines for addictions and drug overdose. The company offers NARCAN nasal spray, a treatment to reverse opioid overdoses. Its pipeline of product candidates includes medicines for the treatment for opioid overdose reversal; alcohol use disorders; acute cannabinoid overd...

Get notified when there are updates to the investment portfolio of O'Shaughnessy Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on O'Shaughnessy Asset Management, LLC with notifications on news.